Essential Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$192K Buy
1,683
+1,564
+1,314% +$184K 0.09% 253
2026
Q2
$12.7K Buy
119
+109
+1,090% +$13.2K 0.01% 1103
2026
Q1
$1.64K Sell
10
-58
-85% -$8.92K ﹤0.01% 2081
2025
Q4
$11.8K Buy
68
+56
+467% +$10.2K ﹤0.01% 1104
2025
Q3
$1.73K Buy
12
+10
+500% +$1.22K ﹤0.01% 1839
2025
Q2
$201 Buy
+2
New +$153 ﹤0.01% 1940

Other funds holding INSM

Essential Partners's INSM Position: Q3 2026 in Review

Essential Partners increased its Insmed (INSM) stake by 1,314% in Q3 2026, buying an estimated $184K and bringing the position to 1,683 shares worth $192K. The position accounts for 0.09% of the portfolio, ranked #253.

Essential Partners first reported a position in INSM in Q2 2025 and has held it in 6 quarters since. 93 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Essential Partners held 1,683 shares of Insmed worth $192K as of Q3 2026.
  • Essential Partners bought 1,564 Insmed shares in Q3 2026, an estimated $184K.
  • Insmed made up 0.09% of Essential Partners's portfolio in Q3 2026, its #253 holding.
  • Essential Partners first reported a position in Insmed in Q2 2025 and has held it in 6 quarters since.
  • 93 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.